HomeTagsValneva SE

Valneva SE

Healthcare

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

Business Wire - June 21, 2022

Valneva SE, a specialty vaccine company, and Pfizer Inc. announced that they have entered into an Equity Subscription Agreement and have updated the terms...

Healthcare

Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate

Globe Newswire - December 22, 2021

Valneva SE ,a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The...